PPM1D and plasma cell myeloma: NGS amplicon sequencing was performed to identify mutations in exon 6 of the PPM1D gene in peripheral blood mononuclear cells isolated from 75 patients diagnosed with multiple myeloma who had been treated with first-line therapy, high-dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT).